MedTrace Logo

Studies of the Immune Response to Vaccination After Hematopoietic Stem Cell Transplantation

NCT01581164 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 12

Last updated 2015-05-08

No results posted yet for this study

Summary

The purpose of this research study is to perform a serial analysis of immune function using blood cells and sera obtained from patients after vaccination following hematopoietic stem cell transplantation (HSCT). The focus of this study will be to characterize several immune parameters during the clinical course of HSCT and correlate these findings with the effect of vaccination.

Conditions

  • Hematopoietic Stem Cell Transplant

Interventions

BIOLOGICAL

Influenza vaccine

Influenza vaccine: Injection, post transplant

BIOLOGICAL

Varicella vaccine

Varicella vaccine: Injection, post transplant

Sponsors & Collaborators

Principal Investigators

  • Jeffrey Venstrom, MD · University of California, San Francisco

Eligibility

Min Age
5 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-12-31
Primary Completion
2014-12-31
Completion
2014-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01581164 on ClinicalTrials.gov